Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 250 to 1000
    • Primary and study completion dates pushed to Apr 2030
    • Study description expanded, about 53 words
    v4
  2. Primary completion date: Nov 2018
    • Study completion date: Nov 2020
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)
Trial Details
NCT Number NCT00230620
Lead Sponsor Imperial College London
Collaborators: British Heart Foundation
Conditions
(from sponsor)		 Telangiectasia, Hereditary Hemorrhagic
Related terms Telangiectasia, Hereditary Hemorrhagic
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov